Cargando…

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma

RNF183, a member of the E3 ubiquitin ligase, has been shown to involve in carcinogenesis and proposed as one of the biomarkers in Uterine Corpus Endometrial Carcinoma (UCEC). However, no research focused on the role of RNF183 in UCEC. We analyzed the expression and immune infiltration of RNF183 in U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Rong, Zheng, Yuhua, Zhao, Lijie, Huang, Xiaobin, Qiang, Rong, Zhang, Rujian, Guo, Xiaoling, Li, Ruiman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726321/ https://www.ncbi.nlm.nih.gov/pubmed/33324448 http://dx.doi.org/10.3389/fgene.2020.595733

Ejemplares similares

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments
por: Geng, Rong, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
por: Chen, Yun
Publicado: (2022)

COVID-19–associated lncRNAs as predictors of survival in uterine corpus endometrial carcinoma: A prognostic model
por: Ding, Yang, et al.
Publicado: (2022)

Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma
por: Liu, Da, et al.
Publicado: (2021)

Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma
por: Yu, Cong, et al.
Publicado: (2022)

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma
por: Xie, Bing-fan, et al.
Publicado: (2022)

The Role of Tissue-Specific Ubiquitin Ligases, RNF183, RNF186, RNF182 and RNF152, in Disease and Biological Function
por: Okamoto, Takumi, et al.
Publicado: (2020)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis
por: Li, Haixia, et al.
Publicado: (2023)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

Immune Infiltrates of m5C RNA Methylation-Related LncRNAs in Uterine Corpus Endometrial Carcinoma
por: Gu, Wen-Xiu, et al.
Publicado: (2022)

Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma
por: Wang, Fei, et al.
Publicado: (2022)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Retracted: Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer
por: Liao, Xia, et al.
Publicado: (2020)

The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma
por: Huang, Xiaoling, et al.
Publicado: (2022)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
por: Lin, Zhiheng, et al.
Publicado: (2022)

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
por: Lu, Xiaoyuan, et al.
Publicado: (2022)

RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis
por: Geng, Rong, et al.
Publicado: (2017)

Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin
por: Li, Yongming, et al.
Publicado: (2021)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma
por: Yao, Yong, et al.
Publicado: (2022)

ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma
por: Liu, Shougang, et al.
Publicado: (2021)

Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma
por: Hu, Panwei, et al.
Publicado: (2023)

The Analysis of Gene Expression Data Incorporating Tumor Purity Information
por: Ahn, Seungjun, et al.
Publicado: (2021)

High expression of the ferroptosis‐associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma
por: Yan, Jianing, et al.
Publicado: (2022)

The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma
por: Gu, Chunyan, et al.
Publicado: (2022)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2020)

ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model
por: Cui, Yun-Qian, et al.
Publicado: (2021)

A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence
por: Gao, Lulu, et al.
Publicado: (2022)

MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma
por: Chen, Junyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_daamvkrld3r2t2vi6gmdhpj1o2